Similarly, there was a significant reduction in TUNEL+NeuN+ cells in the drug-treated mice (stroke+vehicle = 16.85 ± 3.01% vs. stroke+NWL283 = 6.73 ± 0.10%, TUNEL+NeuN+/DAPI+ cells) (p = 0.036) (Figure S1). The gene discussed is RBFOX3; the disease is stroke disorder.